Literature DB >> 8501210

Chlamydia trachomatis infection in a high-risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow-up.

W H Vogels1, P C van Voorst Vader, F P Schröder.   

Abstract

A study to compare the polymerase chain reaction (PCR) test with the cell culture method in diagnosing urogenital Chlamydia trachomatis infections was performed. From 497 patients (212 women, 285 men) attending an outpatient clinic for sexually transmitted diseases, a total of 814 samples (female patients, cervix and urethra; male patients, urethra) were collected. This total included follow-up samples from 35 women and 35 men positive for C. trachomatis by cell culture and/or PCR test, which were collected 2 weeks after treatment with doxycycline (two 100-mg doses per day for 7 days). The PCR test was performed directly on clinical samples without performing phenol-chloroform extraction and ethanol precipitation of DNA. The prevalence of C. trachomatis as measured by positive cell culture was 64 of 497 (12.9%) for all patients, 31 of 212 (14.6%) for women, and 33 of 285 (11.6%) for men. The prevalences as measured by positive PCR test were 71 of 497 (14.3%), 36 of 212 (17.0%), and 35 of 285 (12.3%), respectively. The sensitivities of the cell culture and the PCR test compared with that of true-positive samples were 77.5 to 78.4% and 99.0 to 100.0%, respectively. Discrepancies between cell culture and the PCR test were found for 23 of 497 patients (4.9%), 19 of 212 females (9.0%), and 4 of 285 males (1.4%). Nineteen pretreatment samples from 19 patients (4 female endocervical, 13 female urethral, and 2 male urethral samples) were cell culture negative and PCR test positive, while 1 pretreatment female endocervical sample was cell culture positive and PCR test negative. The posttreatment samples from all patients were cell culture negative, but the PCR test remained positive for 3 of 70 patients (1 female endocervical and 2 male urethral samples). One of these samples became spontaneously negative in three more weeks. The medical history of the individual patient and the negative PCR tests after treatment for nearly all patients support our hypothesis that the positive PCR test results were clinically relevant for the cell culture-negative but PCR test-positive but PCR test-positive patients of the population studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501210      PMCID: PMC262886          DOI: 10.1128/jcm.31.5.1103-1107.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Laboratory techniques for the diagnosis of chlamydial infections.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  Genitourin Med       Date:  1991-06

2.  Use of polymerase chain reaction for detection of Chlamydia trachomatis.

Authors:  L Ostergaard; S Birkelund; G Christiansen
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens.

Authors:  J B Mahony; M A Chernesky
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

4.  Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens.

Authors:  R B Jones; B P Katz; B van der Pol; V A Caine; B E Batteiger; W J Newhall
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

5.  The effect of media and temperature on the storage of Chlamydia trachomatis.

Authors:  S L Aarnaes; E M Peterson; L M De La Maza
Journal:  Am J Clin Pathol       Date:  1984-02       Impact factor: 2.493

6.  Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J A Kluytmans; H G Niesters; J W Mouton; W G Quint; J A Ijpelaar; J H Van Rijsoort-Vos; L Habbema; E Stolz; M F Michel; J H Wagenvoort
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

7.  Chlamydia trachomatis: its role in tubal infertility.

Authors:  R C Brunham; I W Maclean; B Binns; R W Peeling
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

8.  Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics.

Authors:  J W Smith; R E Rogers; B P Katz; J F Brickler; P L Lineback; B Van der Pol; R B Jones
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  Comparison of polymerase chain reaction, monoclonal antibody based enzyme immunoassay, and cell culture for detection of Chlamydia trachomatis in genital specimens.

Authors:  C H Wu; M F Lee; S C Yin; D M Yang; S F Cheng
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study.

Authors:  H C Claas; J H Wagenvoort; H G Niesters; T T Tio; J H Van Rijsoort-Vos; W G Quint
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  16 in total

1.  Use of a single swab in multi-microbe or flex trans transport medium for detection of Chlamydia trachomatis by Roche Amplicor PCR and culture in specimens from two different patient populations.

Authors:  C K Fong; J Falcone; M L Landry
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Concurrent gonococcal and chlamydial infection: how best to treat.

Authors:  A J Robinson; G L Ridgway
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Comparison of a polymer conjugate-enhanced enzyme immunoassay to ligase chain reaction for diagnosis of Chlamydia trachomatis in endocervical swabs.

Authors:  M Chernesky; D Jang; D Copes; J Patel; A Petrich; K Biers; A Sproston; J Kapala
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

4.  In situ hybridisation and direct fluorescence antibodies for the detection of Chlamydia trachomatis in synovial tissue from patients with reactive arthritis.

Authors:  J Berlau; U Junker; A Groh; E Straube
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

5.  Evaluation of the Amplicor Chlamydia trachomatis test versus culture in genital samples in various prevalence populations.

Authors:  B de Barbeyrac; I Pellet; B Dutilh; C Bébéar; B Dumon; M Géniaux; C Bébéar
Journal:  Genitourin Med       Date:  1994-06

6.  Comparison of the Amplicor Chlamydia trachomatis test and cell culture for the detection of urogenital chlamydial infections.

Authors:  M A Catry; M J Borrego; J Cardoso; J Azevedo; I Santo
Journal:  Genitourin Med       Date:  1995-08

7.  Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods.

Authors:  A Stary; E Schuh; M Kerschbaumer; B Götz; H Lee
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens.

Authors:  P C Iwen; R A Walker; K L Warren; D M Kelly; S H Hinrichs; J Linder
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR.

Authors:  J Lan; I Melgers; C J Meijer; J M Walboomers; R Roosendaal; C Burger; O P Bleker; A J van den Brule
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification.

Authors:  S A Morré; P T Sillekens; M V Jacobs; S de Blok; J M Ossewaarde; P van Aarle; B van Gemen; J M Walboomers; C J Meijer; A J van den Brule
Journal:  Mol Pathol       Date:  1998-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.